Colin Molloy
University of Glasgow(GB)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Prion Diseases and Protein Misfolding, Neuropeptides and Animal Physiology, Nicotinic Acetylcholine Receptors Study
Most-Cited Works
- → Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice(2013)569 cited
- → Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice(2017)291 cited
- → RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration(2015)248 cited
- → DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDsin Vitroandin Vivo(2018)189 cited
- → From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease(2021)89 cited
- → M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss(2016)79 cited
- → Chemogenetics defines receptor-mediated functions of short chain free fatty acids(2019)71 cited
- → Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs(2020)47 cited
- → Bitopic Binding Mode of an M1 Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes(2018)30 cited
- → Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease(2021)24 cited